TCI Wealth Advisors’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-16
Closed -$949 2669
2022
Q4
$949 Buy
+16
New +$1.07K ﹤0.01% 2123
2022
Q3
Sell
-10
Closed -$1K 2660
2022
Q2
$1K Buy
10
+6
+150% +$704 ﹤0.01% 2228
2022
Q1
$1K Buy
+4
New +$926 ﹤0.01% 2179

Other funds holding OMIC

TCI Wealth Advisors's OMIC Position: Q1 2023 in Review

TCI Wealth Advisors sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2023, closing a stake of 16 shares — an estimated $949 sold.

TCI Wealth Advisors first reported a position in OMIC in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 66 funds tracked by Wall St. Rank hold OMIC as of Q1 2023.

  • TCI Wealth Advisors reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 16 Singular Genomics Systems, Inc. Common Stock shares in Q1 2023, an estimated $949.
  • TCI Wealth Advisors first reported a position in Singular Genomics Systems, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • TCI Wealth Advisors's Singular Genomics Systems, Inc. Common Stock position peaked at $1K in Q2 2022.
  • 66 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2023.

Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.